ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.

Frederick F Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.